Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis

Abstract Ankylosing spondylitis (AS) is a chronic inflammatory osteoarticular disease. Although the etiology remains unknown, proinflammatory cytokines, such as tumor necrosis factor α and interleukin-6, have been implicated in the development of AS. Here, we report that a patient with AS, whose dis...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Shima, Yoshihito [verfasserIn]

Tomita, Tetsuya [verfasserIn]

Ishii, Taeko [verfasserIn]

Morishima, Atsuyoshi [verfasserIn]

Maeda, Yuichi [verfasserIn]

Ogata, Atsushi [verfasserIn]

Kishimoto, Tadamitsu [verfasserIn]

Tanaka, Toshio [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2011

Schlagwörter:

Ankylosing spondylitis

IL-6

Tocilizumab

Übergeordnetes Werk:

Enthalten in: Modern rheumatology - Oxford : Oxford University Press, 2000, 21(2011), 4 vom: 09. Feb., Seite 436-439

Übergeordnetes Werk:

volume:21 ; year:2011 ; number:4 ; day:09 ; month:02 ; pages:436-439

Links:

Volltext

DOI / URN:

10.1007/s10165-011-0416-9

Katalog-ID:

SPR009024565

Nicht das Richtige dabei?

Schreiben Sie uns!